72 related articles for article (PubMed ID: 3664493)
1. Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeys.
Arndt CA; Colvin OM; Balis FM; Lester CM; Johnson G; Poplack DG
Cancer Res; 1987 Nov; 47(22):5932-4. PubMed ID: 3664493
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal 4-hydroperoxycyclophosphamide: neurotoxicity, cerebrospinal fluid pharmacokinetics, and antitumor activity in a rabbit model of VX2 leptomeningeal carcinomatosis.
Phillips PC; Than TT; Cork LC; Hilton J; Carson BS; Colvin OM; Grochow LB
Cancer Res; 1992 Nov; 52(22):6168-74. PubMed ID: 1423260
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid penetration of active metabolites of cyclophosphamide and ifosfamide in rhesus monkeys.
Arndt CA; Balis FM; McCully CL; Colvin OM; Poplack DG
Cancer Res; 1988 Apr; 48(8):2113-5. PubMed ID: 3349482
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.
Blaney SM; Balis FM; Berg S; Arndt CA; Heideman R; Geyer JR; Packer R; Adamson PC; Jaeckle K; Klenke R; Aikin A; Murphy R; McCully C; Poplack DG
J Clin Oncol; 2005 Mar; 23(7):1555-63. PubMed ID: 15735131
[TBL] [Abstract][Full Text] [Related]
6. Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis.
Fuchs HE; Archer GE; Colvin OM; Bigner SH; Schuster JM; Fuller GN; Muhlbaier LH; Schold SC; Friedman HS; Bigner DD
Cancer Res; 1990 Mar; 50(6):1954-9. PubMed ID: 2306744
[TBL] [Abstract][Full Text] [Related]
7. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans.
Riccardi R; Holcenberg JS; Glaubiger DL; Wood JH; Poplack DG
Cancer Res; 1981 Nov; 41(11 Pt 1):4554-8. PubMed ID: 6895481
[TBL] [Abstract][Full Text] [Related]
8. Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates.
Blaney SM; Cole DE; Balis FM; Godwin K; Poplack DG
Cancer Res; 1993 Feb; 53(4):725-7. PubMed ID: 8428353
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans.
Strong JM; Collins JM; Lester C; Poplack DG
Cancer Res; 1986 Dec; 46(12 Pt 1):6101-4. PubMed ID: 3096555
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of IgG and IgM anti-ganglioside antibodies in rats and monkeys after intrathecal administration.
Bergman I; Burckart GJ; Pohl CR; Venkataramanan R; Barmada MA; Griffin JA; Cheung NK
J Pharmacol Exp Ther; 1998 Jan; 284(1):111-5. PubMed ID: 9435168
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents.
Muraszko K; Sung C; Walbridge S; Greenfield L; Dedrick RL; Oldfield EH; Youle RJ
Cancer Res; 1993 Aug; 53(16):3752-7. PubMed ID: 8339287
[TBL] [Abstract][Full Text] [Related]
12. Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide.
Schuster JM; Friedman HS; Archer GE; Fuchs HE; McLendon RE; Colvin OM; Bigner DD
Cancer Res; 1993 May; 53(10 Suppl):2338-43. PubMed ID: 8485721
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain.
Fung LK; Ewend MG; Sills A; Sipos EP; Thompson R; Watts M; Colvin OM; Brem H; Saltzman WM
Cancer Res; 1998 Feb; 58(4):672-84. PubMed ID: 9485020
[TBL] [Abstract][Full Text] [Related]
14. A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma.
Zamboni WC; Gajjar AJ; Mandrell TD; Einhaus SL; Danks MK; Rogers WP; Heideman RL; Houghton PJ; Stewart CF
Clin Cancer Res; 1998 Oct; 4(10):2537-44. PubMed ID: 9796988
[TBL] [Abstract][Full Text] [Related]
15. Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeys.
McGovren JP; Stewart JC; Elfring GL; Smith RB; Soares N; Wood JH; Poplack DG; Von Hoff DD
Cancer Treat Rep; 1982 Jun; 66(6):1333-41. PubMed ID: 7083237
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid and plasma pharmacokinetics of high doses of 1-beta-D-arabinofuranosylcytosine in nonhuman primates.
Lopez JA; Beardsley GP; Krikorian JG; Mortara RW; Agarwal RP
Cancer Res; 1983 Nov; 43(11):5190-3. PubMed ID: 6616454
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates.
Jackson DV; Castle MC; Poplack DG; Bender RA
Cancer Res; 1980 Mar; 40(3):722-4. PubMed ID: 7471091
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal administration of topotecan in nonhuman primates.
Blaney SM; Cole DE; Godwin K; Sung C; Poplack DG; Balis FM
Cancer Chemother Pharmacol; 1995; 36(2):121-4. PubMed ID: 7767947
[TBL] [Abstract][Full Text] [Related]
19. Cerebral subarachnoid sampling of cerebrospinal fluid in the rhesus monkey.
Bacher JD; Balis FM; McCully CL; Godwin KS
Lab Anim Sci; 1994 Apr; 44(2):148-52. PubMed ID: 8028278
[TBL] [Abstract][Full Text] [Related]
20. Plasma and cerebrospinal fluid pharmacokinetics of rebeccamycin (NSC 655649) in nonhuman primates.
Berg SL; Aleksic A; McGuffey L; Dauser R; Nuchtern J; Bernacky B; Blaney SM
Cancer Chemother Pharmacol; 2004 Aug; 54(2):127-30. PubMed ID: 15150671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
